CYTOKINETICS INC — Director's Dealing 2025

Jan 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-01-02

Reporting Person: Wysenski Nancy (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-02	Common Stock	A	127	$48.93	Acquired	23115	Direct

Footnotes

F1: Director Stock in Lieu of Cash Retainer Program